The efficacy of Fumaria parviflora L. versus gabapentin on pruritus of patients undergoing hemodialysis
- Conditions
- remic prururitus in dialysis patient.Pruritus
- Registration Number
- IRCT20121031011341N11
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
The hemodialysis patient who has uncontrollable pruritus and now at least 1 week doesn't use any antipruritus medication
who had pruritus for at least 6 weeks
patient must have normal range phosphor and potassium in the past month
Parathyroid Hormone (PTH) must be lower than 500
measured visual analogue scale (VAS) score must be four or more
They do not have liver disease, a history of convulsions, or a specific skin disease that causes itching, and they do not have hemolytic blood disease.
Patients who complain of itching for the first time are not included in the study
If the patient was taking medication that interacted with gabapentin or Fumaria parviflora L., he was not included in the study
Those who are allergic to Fumaria parviflora L. or Gabapentin are not included in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Itching score in the 5-D pruritus questionnaire. Timepoint: Before the start of the intervention (the beginning of the study) and two months later (the end of the study). Method of measurement: 5D itch questionnaire.
- Secondary Outcome Measures
Name Time Method Quality of life score in DLQI questionnaire. Timepoint: Before the start of the intervention (the beginning of the study) and two months later (the end of the study). Method of measurement: DLQI quality of life questionnaire.